Abstract
Here, we review the armamentarium on in vitro/ex vivo models of HIV sexual transmission and discuss how these models can be applied to study candidate microbicides.
Keywords: HIV, transmission, microbicides, vagina, cervix, in vitro, modeling, tenofovir, infection, secretions
Current HIV Research
Title: Ex Vivo Models of HIV Sexual Transmission and Microbicide Development
Volume: 10 Issue: 1
Author(s): Kevin K. Arien, Jordan K. Kyongo and Guido Vanham
Affiliation:
Keywords: HIV, transmission, microbicides, vagina, cervix, in vitro, modeling, tenofovir, infection, secretions
Abstract: Here, we review the armamentarium on in vitro/ex vivo models of HIV sexual transmission and discuss how these models can be applied to study candidate microbicides.
Export Options
About this article
Cite this article as:
K. Arien Kevin, K. Kyongo Jordan and Vanham Guido, Ex Vivo Models of HIV Sexual Transmission and Microbicide Development, Current HIV Research 2012; 10 (1) . https://dx.doi.org/10.2174/157016212799304661
DOI https://dx.doi.org/10.2174/157016212799304661 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current View on the Mechanism of Action of Perifosine in Cancer
Anti-Cancer Agents in Medicinal Chemistry Antimicrobial and Chemopreventive Properties of Herbs and Spices
Current Medicinal Chemistry Prioritizing Disease Genes by Using Search Engine Algorithm
Current Bioinformatics Translating Cancer Biomarker Discoveries to Clinical Tests: What should be Considered?
Recent Patents on Biomarkers Synthetic Lethality and PARP-Inhibitors in Oral and Head & Neck Cancer
Current Pharmaceutical Design Chemotherapy with si-RNA and Anti-Cancer Drugs
Current Drug Delivery Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets Rationale and Design of the CAN Study: an RCT of Survival after Propofol- or Sevoflurane-based Anesthesia for Cancer Surgery
Current Pharmaceutical Design p53: A Guide to Apoptosis
Current Cancer Drug Targets Pharmacological Approaches for BRCA1/2 Related Breast and Ovarian Cancer: Preclinical Studies and Early Clinical Trials
Current Women`s Health Reviews Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence
Current Pharmaceutical Design Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...
Current Pharmaceutical Design Effect of Substituted Benzimidazoles and Somatostatin Analogs on the Vitality of Tumor Cell Lines and on the Oxidative Burst of Phagocytes
Letters in Drug Design & Discovery Repurposing Drugs for Cancer Prevention
Current Topics in Medicinal Chemistry Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Targeted Therapy of Breast Cancer
Current Pharmaceutical Design Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression
MicroRNA Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
Current Pharmaceutical Design Inhibitors of Vascular Endothelial Growth Factor in Cancer
Cardiovascular & Hematological Agents in Medicinal Chemistry